| Just Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Moving Relocating > Removing Incoming Email in MS Exchange, C# Example |
|
Just Answers - Removing Incoming Email in MS Exchange, C# Example
The purpose of one of our projects was MS Exchange handler for processing incoming email. The basic source of knowledge According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product was this article "Developing Managed Event Sinks/Hooks for Exchange Server Store using C#" by Logu Krishnan, published ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in to the address http://www.codepro lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ject.com/csharp/CsManagedEventSinksHooks.asp, and also examples from Microsoft Exchange SDK. We utilized Synchronou here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe Events and created the handler, which fires on OnSyncSave event. The handler creates activity record in Microsoft CRM d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro and then removes the message in the Exchange database before the commitment: public void OnSyncSave(IExStoreEventInfo p ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc EventInfo, string bstrURLItem, int IFlags) {
try {
if (IFlags == ((int)EVT_SINK_FLAGS.EVT_SYNC_COMMITTED + (int)EVT_SI easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi K_FLAGS.EVT_IS_DELIVERED)) { ProcessMessage(pEventInfo, bstrURLItem, IFlags); } } catch (Exception ex) { log.Debug( nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ex.Message + "\n" + ex.StackTrace); } finally { LogManager.Shutdown(); } } For Exchange handlers debugging - it is and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the extremely convenient to use system log4net in RollingLogFileAppender or RemoteAppender modes (for multiple instance ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi of COM + objects). You can read more on this subject here http://logging.apache.org/log4net/
To allow the handler incom ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ing mail removal, it is necessary to give proper rights to the user, under which account the COM+ application runs the h dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod andler. These are rights on change of the information in user’s boxes for whom it is registered (Windows 2003 Server: Ac cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin tive Directory Users and Computer -> Users -> Properties (for COM+ application account) -> Exchange Advanced -> Mailbox tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ights). And now the code: private void DeleteMessage(string bstrURLItem) { try { ADODB.Connection oCn = new ADODB.Con t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel nection(); oCn.Provider = "exoledb.datasource"; oCn.Open(bstrURLItem, "", "", -1); if(oCn.State == 1) { log.Debug("G ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ood Connection"); } else { log.Debug("Bad Connection"); } ADODB.Record rec = new ADODB.Record(); rec.Open(bstrURLI y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products em, oCn, ADODB.ConnectModeEnum.adModeReadWrite, ADODB.RecordCreateOptionsEnum.adFailIfNotExists, ADODB.RecordOpenOpti . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de onsEnum.adOpenSource, "", ""); rec.DeleteRecord(bstrURLItem, false); rec.Close(); oCn.Close(); rec = null; oCn = n elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ull; } catch (Exception ex) { log.Debug(ex.Message + "\n" + ex.StackTrace); } } Happy customizing! Boris Makushki tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:0% Interest Credit Cards - Truth or Fiction? Property Tax Grievances - Should You File for a Reduction?
|